by Steve Kirsch
This excellent article is from almost 2 years ago, but it remains as true today as it was back then. They hide the data to prevent independent review. Remember the CDC masking study showing mandates worked? They made the mistake of releasing the data and researchers discovered that the CDC just cherry picked the data to make their conclusion and the data actually showed masking didn’t work.
History shows that hiding clinical trial data can be deadly.
Vioxx is a well-known example of how the US drug regulator withheld important information about the harms of the drug for over three years, before it was withdrawn from the market and tens of thousands of people died as a consequence.
Numerous initiatives have been launched over the past two decades to improve access to trial data after it became evident that what was reported in peer-reviewed journals was often cherry-picked and misleading.
Eminent scientists have succeeded in gaining access to trial data from the European and Canadian drug regulators, but a recent analysis published in the Journal of Law, Medicine, & Ethics, found that the US FDA still lags behind others when it comes to data transparency.